Table 2.
Association between sTNFRs and CKD stages according to the GFR strata in the Kidney Disease Improving Global Outcomes guidelines
| CKD Stage | eGFR (ml/min per 1.73 m2) | ULSAM | PIVUS | |||
|---|---|---|---|---|---|---|
| Participants (n) | Mean sTNFR1±SD | Participants (n) | Mean sTNFR1±SD | Mean sTNFR2±SD | ||
| G1: Normal or high | ≥90 | 108 | 1613±507 | 87 | 1812±356 | 4993±3551 |
| G2: Mildly decreased | 60–89 | 511 | 1973±641 | 450 | 2186±449 | 5727±1692 |
| G3a–b: Mildly to severely decreased | 30–60 | 147 | 2546±834 | 262 | 2924±1425 | 7412±2492 |
| G4: Severely decreased | 15–29 | 11 | 5504±2315 | 10 | 4343±995 | 10,107±2088 |
| G5: Kidney failure | 0–14 | 0 | – | 0 | – | – |
| ANOVA P value | <0.001 | <0.001 | <0.001 | |||